GRTX Research and Charts

GRTX - Galera Therapeutics Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-01-02)

Last 0.04	Change ⇓ -0.01 (0.00%)	Volume 836,616
	Open 0.05	High 0.05	Low 0.04

8EMA (Daily) 0.04	40EMA (Daily) 0.04	50EMA (Daily) 0.04	STO (Daily) 63.333	MACD Hist (Daily) 0.004
8EMA (Weekly) 0.039	40EMA (Weekly) 0.15	50EMA (Weekly) 0.22	STO (Weekly) 20.667	MACD Hist (Weekly) 0.017


Company Profile
Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer. Its lead product candidate, GC4419, is a small molecule dismutase mimetic developed for the reduction of severe oral mucositis, or SOM.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.